Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anas Islam

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Recent Advances in Anti-Infective Drug Discovery|July 4, 2025
Advances in Microbiome Research: Implications for Infectious Disease Management and TreatmentAnas Islam
Drug Research|June 12, 2023
Phytopharmaceuticals and Herbal Approaches to Target Neurodegenerative DisordersAnas Islam, Anuradha Mishra, Rabia Ahsan, et al.
Current Protein & Peptide Science|April 20, 2026
Targeting Drug-Resistant Tuberculosis with Antimicrobial Peptides: Opportunities and ChallengesAsad Ahmad, Rufaida Wasim, Anas Islam, et al.
Drug Research|July 28, 2021
Recapitulation of Evidence of Phytochemical, Pharmacokinetic and Biomedical Application of SilybinAnas Islam, Anuradha Mishra, Md Aftab Siddiqui, et al.
The Yale Journal of Biology and Medicine|July 1, 2025
Nanotechnology-driven Epigenetic Cancer Therapy: Precision Delivery and Sustained Release of DNA Methylation ModulatorsUsama Ahmad, Anas Islam, Mohd Muazzam Khan, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 9, 2025
Exploring NMDAR pathways in ischemic stroke: implications for neurotoxic and neuroprotective mechanisms and therapeutic strategiesSara Khan, Mohd Muazzam Khan, Badruddeen, et al.
Diabetes Research and Clinical Practice|March 16, 2026
Impact of angiopoietin-like 4 (ANGPTL4) protein and O-linked β-N-acetylglucosamine(O-GlcNAc) in diabetic nephropathyAbhishek Pandey, Badruddeen, Juber Akhtar, et al.
Advances in Immunology|July 30, 2025
Personalized precision: Revolutionizing cancer treatment with mRNA-based vaccines in melanoma therapyKrishnendu Adhikary, Abhik Paul, Ayush Madan, et al.
Cardiovascular Toxicology|September 6, 2024
High Mobility Group Box 1 and Cardiovascular Diseases: Study of Act and ConnectRufaida Wasim, Aditya Singh, Anas Islam, et al.
The Yale Journal of Biology and Medicine|January 1, 2026
Exploring EGCG for Leishmaniasis: A Natural Strategy for Neglected Disease InterventionKhan Aejaz Ahmed, Usama Ahmad, Juber Akhtar, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Recent Advances in Anti-Infective Drug Discovery|July 4, 2025
Advances in Microbiome Research: Implications for Infectious Disease Management and TreatmentAnas Islam
Drug Research|June 12, 2023
Phytopharmaceuticals and Herbal Approaches to Target Neurodegenerative DisordersAnas Islam, Anuradha Mishra, Rabia Ahsan, et al.
Current Protein & Peptide Science|April 20, 2026
Targeting Drug-Resistant Tuberculosis with Antimicrobial Peptides: Opportunities and ChallengesAsad Ahmad, Rufaida Wasim, Anas Islam, et al.
Drug Research|July 28, 2021
Recapitulation of Evidence of Phytochemical, Pharmacokinetic and Biomedical Application of SilybinAnas Islam, Anuradha Mishra, Md Aftab Siddiqui, et al.
The Yale Journal of Biology and Medicine|July 1, 2025
Nanotechnology-driven Epigenetic Cancer Therapy: Precision Delivery and Sustained Release of DNA Methylation ModulatorsUsama Ahmad, Anas Islam, Mohd Muazzam Khan, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 9, 2025
Exploring NMDAR pathways in ischemic stroke: implications for neurotoxic and neuroprotective mechanisms and therapeutic strategiesSara Khan, Mohd Muazzam Khan, Badruddeen, et al.
Diabetes Research and Clinical Practice|March 16, 2026
Impact of angiopoietin-like 4 (ANGPTL4) protein and O-linked β-N-acetylglucosamine(O-GlcNAc) in diabetic nephropathyAbhishek Pandey, Badruddeen, Juber Akhtar, et al.
Advances in Immunology|July 30, 2025
Personalized precision: Revolutionizing cancer treatment with mRNA-based vaccines in melanoma therapyKrishnendu Adhikary, Abhik Paul, Ayush Madan, et al.
Cardiovascular Toxicology|September 6, 2024
High Mobility Group Box 1 and Cardiovascular Diseases: Study of Act and ConnectRufaida Wasim, Aditya Singh, Anas Islam, et al.
The Yale Journal of Biology and Medicine|January 1, 2026
Exploring EGCG for Leishmaniasis: A Natural Strategy for Neglected Disease InterventionKhan Aejaz Ahmed, Usama Ahmad, Juber Akhtar, et al.
Pageof 6